Related Experiment Video
Updated: Jul 19, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Trends, challenges, and success factors in pharmaceutical portfolio management: Cognitive biases in decision-making
Linn Bieske1, Maximillian Zinner1, Florian Dahlhausen1
1Faculty of Health, Witten/Herdecke University, Germany.
Abstract:
Effective portfolio management is crucial for innovation and sustaining revenue in pharmaceutical companies. This article holistically reviews trends, challenges, and approaches to pharmaceutical portfolio management and focuses, in particular, on cognitive biases in portfolio decision-making. Portfolio managers strongly rely on external innovation and face increasing competitive pressure and portfolio complexity. The ability to address biases and make robust decisions remains a challenge. Portfolio management practitioners most commonly face confirmation bias, champion bias, or misaligned incentives, which they seek to mitigate through expert input, team diversity, and rewarding truth-seeking. Ultimately, highest-quality portfolio management decision-making could be enabled by three factors: high-quality data, structured review processes, and comprehensive mitigating measures against biases in decision-making.
More Related Videos
Related Concept Videos
Factors Affecting Drug Response: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Desensitization and Tachyphylaxis
Drug Control Governance: Regulatory Bodies and Their Impact
Biopharmaceutics and Pharmacokinetics: Overview
Drug Discovery: Overview

